NICE gives nod to rivaroxaban as treatment for pulmonary embolism

04/19/2013 | Fox Business

The U.K.'s National Institute for Health and Care Excellence has endorsed the use of anti-clotting drug rivaroxaban in patients with pulmonary embolism. The decision gives doctors an alternative to combined heparin and warfarin to reduce the risk of a repeat embolism.

View Full Article in:

Fox Business

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ